What evidence exists to support antiviral treatment in children with chronic hepatitis B?

Raffaele Iorio1, Maria Tufano, Maria G Giagnorio

  • 1Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.

Antiviral Therapy
|November 7, 2013
PubMed

Insights

Optimal management for children with chronic hepatitis B (HBV) remains unclear. Current therapies offer limited benefits and potential side effects, necessitating careful consideration against the disease's natural course.

Area of Science:

  • Pediatric Hepatology
  • Viral Hepatitis Management
  • Infectious Diseases in Children

Background:

  • Chronic hepatitis B (HBV) infection in children often presents as a mild condition.
  • Current therapeutic interventions for pediatric HBV demonstrate partial efficacy, primarily in specific patient subgroups.
  • Available antiviral drugs for chronic HBV lack proven long-term advantages over untreated disease and present numerous limitations.

Purpose of the Study:

  • To critically appraise existing studies on the natural history of chronic hepatitis B in children.
  • To evaluate the long-term outcomes of current therapeutic schedules for pediatric HBV infection.
  • To inform decision-making regarding the balance between treatment benefits, side effects, and the natural disease progression.

Main Methods:

  • Critical appraisal of published literature on pediatric chronic hepatitis B.
  • Review of studies examining the natural history of HBV in children.
  • Analysis of long-term data from therapeutic interventions in pediatric HBV cohorts.

Main Results:

  • The optimal management strategy for chronically HBV-infected children is not well-defined.
  • Therapeutic responses in pediatric HBV are often partial and subgroup-dependent.
  • Available HBV treatments show limited proven benefit on the long-term disease course compared to no treatment.

Conclusions:

  • A careful balance is required between the potential benefits and side effects of HBV treatment in children.
  • The natural course of untreated chronic hepatitis B in children warrants consideration in management decisions.
  • Further research is needed to establish evidence-based guidelines for pediatric HBV management.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K